Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of JNJ-42160443 as Monotherapy in Subjects With Moderate to Severe, Chronic Knee Pain From Osteoarthritis
Conditions
Interventions
Oxycodone CR (standard pain medication)
JNJ-42160443
+2 more
Locations
44
United States
Tucson, Arizona, United States
Carmichael, California, United States
Pismo Beach, California, United States
Clearwater, Florida, United States
Hallandale, Florida, United States
Oldsmar, Florida, United States
Start Date
April 20, 2010
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
March 11, 2020
NCT07551245
NCT06755697
NCT06702046
NCT07547774
NCT07548385
NCT05883540
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions